2021 Clinical Proteomics Tumor Analysis Consortium (CPTAC) Annual Scientific Symposium
Register for the 2021 Clinical Proteomics Tumor Analysis Consortium (CPTAC) Virtual Scientific Symposium to hear CPTAC investigators share their latest discoveries in the field of cancer proteogenomics, cancer research, and data analysis tools.
In addition to scientific talks on tumor biology and translational studies, there will be demonstrations of these CPTAC-developed data analysis tools:
- FragPipe Computational Pipeline (for comprehensive analysis of mass spectrometry-based proteomics data)
- ProTrack-Kinase Activity Portal (for querying/visualizing/downloading kinase activity scores of multiple cancer types)
- BayesDebulk (analysis method for inferring cell-type composition in bulk tissue using proteogenomics data)
The CPTAC program is a national effort coordinated through NCI’s Office of Cancer Clinical Proteomics Research to accelerate the understanding of cancer biology through the marriage of large-scale proteome and genome analysis, or proteogenomics. Proteogenomics allows CPTAC researchers to paint a more detailed picture of tumor carcinogenesis and progression, micro-environments, and immune landscapes. This information can then be leveraged therapeutically to improve patient care.